跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
oridonin
首页
药物
oridonin
oridonin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Composition for the Treatment of Resistant Cancers Comprising Oridonin
US 2010016420 A1
申请人: CHEN SOPHIE
优先权: 2006
EP
US
WO
4 件公开
Cosmetic compositions comprising oridonin and new cosmetic uses
US 9050477 B2
申请人: FOURNIAL ARNAUD
优先权: 2009
EP
US
WO
4 件公开
1-OXO/ACYLATION-14-ACYLATED ORIDONIN DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
US 2014364490 A1
申请人: HANGZHOU BENSHENG PHARMACEUTICAL CO LTD
优先权: 2012
CN
US
2 件公开
REAGENT FOR TARGETING DEGRADATION OF BCR-ABL PROTEIN AND USE IN PREPARATION OF PHILADELPHIA CHROMOSOME-POSITIVE TUMOR-CURING MEDICINE
WO 2014048109 A1
申请人: UNIV SUN YAT SEN
优先权: 2012
CN
WO
2 件公开
Oridonin analogs, compositions, and methods related thereto
US 9725460 B2
申请人: UNIV TEXAS
优先权: 2015
US
2 件公开
Anti-cancer agents and method of use thereof
US 2003035851 A1
申请人: CHEN SOPHIE
优先权: 2002
US
Technical method for extracting oridinin from rabdosia rubescens
CN 1528757 A
申请人: UNIV HUADONG TECHNOLOGY
优先权: 2003
CN
Medicine carrying nanometer particles and production thereof
CN 1711989 A
申请人: SHANGHAI CHINESE MEDICINE UNIV
优先权: 2004
CN
Method for extracting oridonin, ponicidin and oleanolic acid using supercritical carbon dioxide method
CN 1736997 B
申请人: UNIV SHENYANG PHARMACEUTICAL
优先权: 2005
CN
Method for separating rubescensinA from rabdosia
CN 1763029 A
申请人: UNIV ZHEJIANG
优先权: 2005
CN
第 1 / 10 页
上一页
下一页
药物
反馈